finasteride has been researched along with Central Serous Chorioretinopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gülkaş, S; Şahin, Ö | 1 |
| Holmes, AJ; Moisseiev, E; Morse, LS; Moshiri, A | 1 |
| Chew, EY; Cukras, C; Forooghian, F; Meleth, AD; Meyerle, CB; Wong, WT | 1 |
1 review(s) available for finasteride and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy
Topics: Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Chronic Disease; Eplerenone; Finasteride; Humans; Laser Therapy; Mineralocorticoid Receptor Antagonists; Photochemotherapy; Photosensitizing Agents; Vascular Endothelial Growth Factor A | 2019 |
2 other study(ies) available for finasteride and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
Finasteride is effective for the treatment of central serous chorioretinopathy.
Topics: 5-alpha Reductase Inhibitors; Administration, Oral; Adult; Aged; Central Serous Chorioretinopathy; Female; Finasteride; Fluorescein Angiography; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Retina; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Young Adult | 2016 |
Finasteride for chronic central serous chorioretinopathy.
Topics: 5-alpha Reductase Inhibitors; Adult; Central Serous Chorioretinopathy; Chronic Disease; Dihydrotestosterone; Finasteride; Fluorescein Angiography; Humans; Hydrocortisone; Male; Middle Aged; Pilot Projects; Prognosis; Prospective Studies; Testosterone; Tomography, Optical Coherence; Visual Acuity | 2011 |